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Using a signal sequence-trap we identiﬁed a human gene encoding a polypeptide of 99 amino acids with a putative
signal sequence. The gene was identical to keratinocyte differentiation-associated protein (Kdap), which was
reported previously by Oomizu et al (Gene 256: 19–27, 2000) to be expressed in embryonal rat epidermis at the
mRNA level. In humans, we found Kdap mRNA expression to be restricted to epithelial tissue at high levels. The
12.5 kDa protein was detected in culture supernatant of keratinocytes and those transfected adenovirally with
the Kdap gene. In normal skin, Kdap protein was found exclusively within lamellar granules of granular keratino-
cytes and in the intercellular space of the stratum corneum. By contrast, in lesional skin of patients with psoriasis,
Kdap was expressed more widely throughout suprabasal keratinocytes. When induced to differentiate in vitro,
keratinocytes showed marked upregulation of Kdap mRNA expression similar to that of involucrin mRNA, but with
differing kinetics. Finally, a spliced variant of Kdap mRNA was generated by alternative splicing mechanisms. Our
studies indicate that human Kdap resembles rat Kdap with respect to tissue and cell expression at the mRNA level
and that Kdap is a low-molecular-weight protein secreted by keratinocytes. Thus Kdap may serve as a soluble
regulator of keratinocyte differentiation.
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As the outermost layer of skin, the epidermis serves as an
interface between internal and external environments. It
consists overwhelmingly of keratinocytes, which originate
from stem cells and transiently amplifying cells in the basal
layers, which in turn proliferate and differentiate first into
spinous keratinocytes and then into granular keratinocytes
(Watt, 2000). The latter cells’ distal outer and inner cell
membranes correspond, respectively, to lipid and protein
envelopes that together form the cornified cell envelope
(CCE). The protein envelope consists of an insoluble
complex of proteins cross-linked by transglutaminase
(TGase) to structural proteins such as involucrin and loricrin,
whereas the lipid envelope consists of a monomolecular
layer of o-hydroxyceramides, covalently linked by ester
bonds to the protein envelope (Kalinin et al, 2001).
The CCE a mechanical barrier that can forestall entry
through the skin of infectious microbes, mutagenic ultra-
violet radiation, noxious chemicals, and other injurious
agents. Recent studies also suggest that it may play an
active role in innate immunity. Molecular cloning and protein
analyses have identified several secreted proteins of low
molecular weight within the CCE (e.g., SKALP/elafin;
cystatins) (Steinert and Marekov, 1995; Ishida-yamamoto
and Iizuka, 1998; Schalkwijk et al, 1999), and functional
studies have shown that many of these proteins exert
proteinase inhibitor activity that may curtail microbial
growth and/or dampen inflammation (Molhuizen and
Schalkwijk, 1995).
Despite recent recognition of CCE components and
elucidation of their functions, it is likely that several
important components of the CCE remain undiscovered.
The identification and elucidation of their function should
improve our understanding of CCE. Hypothesizing that
some of these novel CCE proteins are secreted and
keratinocyte-specific proteins (e.g., involucrin, filagrin, and
loricrin), we employed a previously established signal
sequence (SS)-trap method (Tashiro et al, 1993) to isolate
SS-coding genes from a human keratinocyte cDNA library
because the N-terminal SS is unique to precursors of
secreted and membrane-anchored proteins. SS-trapped
cDNA clones were then screened for keratinocyte-specific
genes using differential colony hybridization (keratinocytes
vs dermal fibroblasts). Our efforts yielded several novel
genes including one encoding a precursor of a secreted,
low-molecular-weight protein expressed selectively in nor-
mal human epidermis by granular keratinocytes. Subse-
quent analyses have revealed the gene to be identical to
keratinocyte differentiation-associated protein (Kdap), iso-
lated by Oomizu et al (2000).
Oomizu et al identified Kdap using subtractive cDNA
cloning of rat embryo skin at 14 vs 17 d of gestation. They
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also isolated cDNA clones for human and mouse homologs
and identified spliced variants of mRNA for each species.
Kdap mRNA was expressed specifically in the suprabasal
layer of embryonal and neonatal rat skin. Because of Kdap’s
specific expression in skin and the possibility that it is
secreted, we hypothesized Kdap to contribute to the
regulation of human epidermal structure and/or function.
Thus, we examined Kdap expression in human skin and
other tissues, and characterized its biochemical properties
and the regulation of gene expression during keratinocyte
differentiation and of in situ protein expression in normal
and psoriatic skin. Our findings expand our knowledge of
Kdap, serving as the basis for further investigation into its
function within epithelial tissue.
Results
Molecular cloning of novel SS-encoding genes ex-
pressed selectively by keratinocytes To identify novel
genes encoding secreted proteins expressed selectively by
keratinocytes, we employed an SS trap (Tashiro et al, 1993)
and differential colony hybridization. Because SS is en-
coded by 50-end cDNA sequences, these sequences were
enriched from cDNA synthesized with mRNA from primary-
cultured human keratinocytes. We then inserted enriched
cDNA into an expression vector to produce a fusion protein
of cDNA-encoded polypeptide and SS-deficient hIL-2Ra.
This cDNA library was transferred into COS-1 cells and
examined for the ability of cDNA to escort hIL-2Ra-lacking
SS to the cell surface, as judged by surface staining using
anti-hIL-2Ra antibody (Ab) (Bonkobara et al, 2003). cDNA
clones exhibiting surface expression were screened further
using differential colony hybridization (Ariizumi et al, 1997)
for genes expressed by keratinocytes, but not by dermal
fibroblasts. These procedures yielded six novel genes
(found in the EST database updated in the year of 2000)
encoding SS that hybridized strongly with total cDNA
probes prepared from keratinocyte mRNA, but only margin-
ally or not at all with dermal fibroblast probes. Finally, full-
length cDNA clones for each of the six EST genes were
isolated and their entire nucleotide sequences were
determined (Bonkobara et al, 2003).
Amino acid structure of an EST clone Among the six EST
genes was one encoding a polypeptide (termed Kdap)
consisting of 99 amino acids with a putative N-terminal SS
of 22 amino acids (Fig 1). Comparison with known proteins
in the human GenBank database (updated in 2000) failed to
identify homologous proteins, but an EST database search
revealed mouse and rat homologs (note that these
sequences were not full-length cDNA clones). Indeed, we
were able to clone the cDNA for these homologs using
RT-PCR of mRNA from mouse and rat skin, respectively;
nucleotide sequences were confirmed by comparison with
EST clones. Analysis of amino acid sequences showed
considerable conservation among the three species (54%–
59% identity) (Fig 1). By contrast, the IYP sequence (located
just after the SS) was found only in the mouse. A homology
search conducted in 2003 revealed that our isolated gene is
identical to Kdap, previously reported by Oomizu et al (2000).
Keratinocyte-predominant expression of Kdap mRNA
As expected, northern blotting of the Kdap gene showed a
transcript of approximately 1 kb expressed by keratino-
cytes, but not by dermal fibroblasts (Fig 2A). Human mRNA
was detected only in the skin at a high level and in the
thymus at a considerably lower level. Similar tissue
specificity was noted for mouse mRNA (Fig 2B). We next
examined RNA expression in different epithelia using RT-
PCR (Fig 2C); there was high expression in oral mucosa,
tongue, esophagus, and stomach, similar to that in the skin;
much lower expression in the bladder and uterus; and no
expression in the gastrointestinal mucosa. These results
indicate that Kdap mRNA is expressed by various epithelia,
especially those predominantly populated by keratinocytes.
Kdap is a secreted protein To determine whether the
N-terminal amino acid sequence of Kdap acts as an SS to
permit its secretion, we transfected an expression vector
(pKdap-Fc) encoding a fusion protein of the entire Kdap
sequence and the Fc portion of human IgG1 into COS-1
cells, and then harvested the supernatant (extracellular
fraction) and whole-cell extracts (intracellular fraction)
separately. Protein expression was determined by western
blotting using anti-human IgG Ab (Fig 3A). Whereas Kdap-
Fc protein was detected clearly as a single band of 49 kDa
in the extracellular fraction, it was barely detectable in the
intracellular fraction (control Ab did not produce specific
bands), indicating that protein is secreted efficiently and
also suggesting that the N-terminal sequence acts as an SS
in transfected cells. To map the SS cleavage site, we used
protein A-affinity chromatography to purify the Fc-fusion
protein from the supernatant and automated Edman
degradation to determine N-terminal amino acid residues.
Our results indicated that the secreted Fc-fusion protein
starts at alanine on amino acid 23, the cleavage site lying
between this amino acid and glycine on amino acid 22 (Fig 1).
For biochemical characterization, we immunized rabbits
with His-tagged recombinant Kdap protein (His-Kdap) to
produce anti-human Kdap Ab. This Ab was used to examine
Kdap secretion (without tags) in COS-1 cells that were gene
transferred using an Adv with full-length Kdap cDNA (Fig
3B). By western blotting, we detected a single band of 12.5
LNIDKLRSAFKADEFLNWHALFESIKRKLPFLNWDAFPKLKGLRSATPDAQ 99
LNFKRLQSAFQSENFLNWHVITDMFKNAFPFINWDFFPKVKGLRSAAPDSQ 102
LNFNKLQSAFKSDDFLNWHVLTDMFKKALPFINWEFFPKVKGLRSAVPDSQ 98
Kdap_H
Kdap_M
Kdap_R
MKIPVLPAVVLLSLLVLHSAQGATLGGPE---EESTIENYASRPEAFNTPF 48Kdap_H
MKIPILPVVALLSLLALHAVQGAALGHPTIYPEDSSYNNYPTATEGLNNEF 51Kdap_M
MKIPILPIVALLSLLALHAAQGAALGTPM---EDTTSSNYPSGTEGLS-EF 47Kdap_R
Figure 1
Amino acid sequences of human keratinocyte
differentiation-associated protein (Kdap). Ami-
no acid sequence (deduced from nucleotide
sequences of human Kdap cDNA, Kdap_H,
GenBank accession number XM_097406) is
aligned with those of mouse (Kdap_M, W30505)
and rat (Kdap_R, AB011028) homologs. Human
Kdap precursor is cleaved between amino acid 22
and 23 (shown by a reverse triangle).
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Figure 2
mRNA expression of human and mouse
keratinocyte differentiation-associated
protein (Kdap). mRNA isolated from pri-
mary-cultured cells and various human (A)
and mouse (B) tissues was examined by
northern blotting for mRNA expression of
Kdap or b-actin. Expression was also
assayed using RT-PCR of RNA isolated
from different mouse epithelial tissues
using RT-PCR (C).
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Figure 3
Protein expression of human keratinocyte differentiation-associated protein (Kdap). Human Kdap protein was characterized by western
blotting of culture supernatant and protein extracts prepared from Kdap gene-transfected cells, primary-cultured keratinocytes, psoriatic or normal
scales. (A) COS-1 cells were transfected with an empty vector (Vector) or an expression vector (pKdap-Fc) encoding for a fusion protein of the entire
sequence of human Kdap (including a signal sequence) and Fc portion of immunoglobulin. At 2 d post-transfection, the culture supernatant (Sup)
was harvested and whole-cell extracts (Cell) were prepared. Aliquots (10% each fraction) were subjected to SDS-PAGE analysis followed by western
blotting, using anti-human IgG Ab. (B) COS-1 cells (left panel) or keratinocytes (right panel) were infected with recombinant Adv encoding Kdap (Adv-
Kdap) or LacZ gene (Adv-LacZ). Likewise, the small aliquots (5% and 10% for COS-1 cells and keratinocytes, respectively) were examined for
expression of Kdap protein. (C) Whole-cell extracts were prepared from primary-cultured keratinocytes and the supernatant was harvested and
concentrated 10–20-fold. Small aliquots (10% each) were applied for SDS-PAGE. (D) Crude extracts (75 mg) prepared from scales psoriatic or
normal scales were assayed by western blotting, using anti-human Kdap Ab or control rabbit IgG.
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kDa in the extracellular fraction and two bands (13.5 and
11.5 kDa) in the intracellular fraction (no bands were
detected with control Ab). The latter bands most likely
correspond to a precursor containing SS and the mature
form, respectively. Ab specificity was confirmed by the
absence of detectable bands in the two fractions of COS-1
cells infected with Adv-LacZ (expression vector for
b-galactosidase gene). We noted the extracellular mature
form (12.5 kDa) to be slightly larger than the intracellular
mature form (11.5 kDa); both mature forms were markedly
larger than the size predicted from the primary amino acid
sequence (8.7 kDa). Similar differences in molecular weights
were also detected using Adv-infected keratinocytes (Fig
3B). Kdap protein was found mostly in the intracellular
fraction, although lower levels were detected in the super-
natant, indicating that secretion was blocked partially in
these infected keratinocytes. This low secretion may be due
to lack of mature lamellar granules (secretory vesicles) in
in vitro cultured keratinocytes (undifferentiated phenotype).
In primary-cultured keratinocytes in which Kdap is synthe-
sized from the endogenous gene (rather than from the
transgene), only small amounts of protein were detected in
both extracellular and intracellular fractions when more
proteins and longer exposure to an X-ray film were involved
(Fig 3C). Nonetheless, secretion of Kdap was proved by
cleavage of N-terminal sequence and detection of Kdap
protein in culture supernatants of transfected (transgene
expression) and non-transfected keratinocytes (endogen-
ous gene expression).
We also examined protein expression of Kdap in crude
extracts prepared from scales of psoriatic or normal skin
(not cultured cells) (Fig 3D). Western blotting using the same
Ab detected two bands in the extracts of psoriatic scales: a
thicker band (21 kDa) and a thinner band (31 kDa). These
molecular weights were about two to three times larger than
the 11.5 kDa detected in the cell extracts of non-transfected
and transfected keratinocytes (Fig 3B). In normal scales,
both bands were also detected, but expression levels were
much lower than in psoriatic scales, suggesting upregulated
expression of Kdap in situ in psoriatic skin. Moreover, the
ratio of the two bands’ intensities was converse to that
found in psoriatic scales. Variations in the molecular weight
of the secreted (matured) Kdap protein were not detected.
By contrast, intracellular Kdap appears to vary, most likely
due to post-translational modification.
In situ expression in human skin Using the previous Ab,
we examined Kdap expression in normal human skin.
Indirect immunofluorescence highlighted the upper spinous
and granular layers on control cryostat sections of the
human epidermis (see arrows in Fig 4A). Staining was
predominantly observed in an alternate wave-like pattern,
with the strongest staining at the apical edges of the
granular cells (inset in Fig 4A). There was little or no staining
of the cornified layer and very weak staining was occa-
sionally seen in the mid-epidermal layers. By contrast, in
lesional skin of psoriatic patients, Kdap was expressed
more widely and at high levels throughout suprabasal
keratinocytes (Fig 4B). This expression pattern in psoriasis
is similar to that reported for SKALP/elafin (Pfundt et al,
1996) and for cystatin M/E (Zeeuwen et al, 2001), both of
which are low-molecular-weight and secreted proteins with
anti-proteinase activity. It should be noted that this more
widespread Kdap expression in psoriasis was not seen in
other cornification disorders, such as the bullous and non-
bullous types of congenital ichthyosiform erythroderma,
lamellar ichthyosis with or without TGM1 mutation, and
palmoplantar keratoderma.
We next examined Kdap mRNA expression in normal
skin using in situ hybridization (Fig 4C). Unlike its protein
expression, Kdap mRNA was detected more widely
throughout suprabasal keratinocytes. This difference be-
tween protein and mRNA expression is reminiscent of
involucrin, an established marker of keratinocyte differen-
tiation (de Viragh et al, 1994). Consistent with the protein
expression, Kdap was not expressed by basal keratino-
cytes, strongly suggesting that Kdap is also a marker of
keratinocyte differentiation.
Kdap is secreted into the extracellular space via lamellar
granules To determine the ultrastructural localization of
Kdap in granular keratinocytes, we conducted immuno-
electron microscopic analysis of normal human epidermis
stained with anti-Kdap Ab and gold particle-conjugated
anti-rabbit IgG (Fig 5). Kdap staining localized to areas
immediately beneath the apical side of the keratinocyte
Normal Skin Psoriatic Skin Normal Skin
in situ hybridizationImmuno-fluorescent staining
A B C
Figure 4
Keratinocyte differentiation-associated protein (Kdap) expression in normal and psoriatic skin. Frozen skin sections prepared from normal
healthy adults (A, C) and psoriatic patients (B) were immunofluorescently stained with anti-Kdap Ab and fluorescein isothiocyanate-conjugated anti-
rabbit Ab (A, B) or hybridized in situ with anti-sense RNA probe for the Kdap gene (C). A higher magnification is provided in inset (A). The granular
layer and stratum corneum are indicated by arrows and arrowheads, respectively (scale bar: 50 mm). No staining was observed with control rabbit
IgG or sense RNA probe. Data shown are representative of staining of skin biopsies from three individuals with psoriasis.
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plasma membrane in the upper suprabasal and granular
layers (Fig 5). These areas were rich in apparently
membrane bound vesicles containing both variably electron
dense material that was consistent with them being
membrane-coating granules (lamellar granules). These
granules could sometimes be seen closely arranged
together in a distinctive pattern beneath the plasma
membrane. By contrast, there were very few Kdap-labeled
vesicles in the region directly above the plasma membrane
(Fig 5A). The position of the labeling was over both the
vesicle plasma membrane and the center of the vesicle
(Fig 5A–C). The morphology of the cryofixed and substi-
tuted control skin often, but not always, failed to reveal the
fine detail of the membrane coating (lamellar) granules as
seen by conventional EM (Fig 5C). Both the size of the
vesicles stained by anti-Kdap Ab and their distribution
pattern within granular keratinocytes strongly suggests that
Kdap is in the lamellar granules or their contents. The Kdap-
containing granules were seen close to the plasma
membrane, and Kdap staining was also observed in the
intercellular space (Fig 5B and D). Morphometric analysis of
Kdap labeling (4750 gold particles) at the outer surface of
the plasma membrane in the upper granular keratinocyte
layers showed a significant proportion (40%) of labeling on
or between the external surfaces of the plasma membrane
or between granular cells in the intercellular spaces (the
majority of the remaining 60% of plasma membrane
labeling was restricted to the lamellar granules subjacent
to the apical plasma membrane (Fig 5B and D). These
results indicate that Kdap is secreted by differentiated
keratinocytes and may be incorporated into the lipid layer
and the external surface of the CCE.
Kdap mRNA expression is upregulated markedly during
keratinocyte differentiation in vitro To examine the effect
of keratinocyte differentiation on Kdap mRNA expression,
we cultured keratinocytes in low-Ca2þ media to maintain
these cells in a basal state, and then induced differentiation
by shifting to high-Ca2þ media containing 10% FCS. Time-
dependent changes in mRNA expression were assessed by
northern blotting, and keratinocyte differentiation was
monitored in parallel by involucrin mRNA expression. In
low-Ca2þ media, both Kdap and involucrin were expressed
at background levels (Fig 6). After shifting to high-Ca2þ
media, involucrin mRNA was increased markedly after 24 h
and this high level was maintained for 4 d. Kdap mRNA was
also upregulated at 24 h (60-fold higher than in untreated
keratinocytes), but unlike involucrin, Kdap’s upregulated
expression lasted for only 2 d. These results indicate that
Kdap (like involucrin) is a marker of keratinocyte differentia-
tion; however, Kdap and invlucrin differ in the kinetics of
mRNA expression during differentiation in vitro.
Figure 5
Keratinocyte differentiation-associated protein (Kdap) protein is
localized to lamellar granules of keratinocytes. After staining normal
skin with anti-Kdap Ab and secondary Ab conjugated with gold
particles, localization of Kdap protein ultrastructually was examined in
the granular keratinocytes. (A) Low magnification: immuno-gold label
(representing Kdap) was found in small vesicles under the apical
plasma membrane of granular keratinocytes (arrows), a localization
similar to that of lamellar granules. Some labeled granules were also
seen fusing with or in close association to the plasma membrane. (B)
Kdap was also present in the intercellular space. (C) Higher magnifica-
tion: although membrane-bound vesicles failed to show the classic
lamellar characteristics of membrane coating granules seen in routine
transmission EM sections, the size and frame structure were identical
to those of lamellar granules (inset). Multiple clusters of lamellar
granule-like vesicles were localized within elongated, electron-lucent
areas of the cytoplasm just under the plasma membrane (arrows). (D)
Kdap was observed close to or on the cell membrane (arrowheads) of
granular keratinocytes (scale bars: 2a 50 nm, 2b, c and d 100 nm).
rRNA
Kdap
Days after Ca2+/FCS
Involucrin
0 1 2 4
Figure6
Expression of keratinocyte differentiation-associated protein
(Kdap) mRNA is markedly induced during in vitro keratinocyte
differentiation. At indicated time points after inducing differentiation
with high-dose Ca2þ , total RNA was isolated from treated cells and
examined by northern blotting for Kdap and involucrin mRNA
expression. Amounts of ribosomal RNA (rRNA) detected by ethidium
bromide staining were similar in all four RNA samples.
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A spliced variant is produced by alternative splicing
mechanisms In isolating a full-length cDNA clone for Kdap
(a transcript), we identified an additional cDNA clone
containing a shorter insert (termed b transcript) (Fig 7A).
Nucleotide sequence analysis showed that the coding
sequence of the b transcript is identical to an alternatively
spliced form (GenBank accession number AA58342) that
was reported by Oomizu et al. Note, however, that the two
transcripts differ in their 30-untranslated region. Amino acid
sequence deduced from the DNA sequences revealed a
deletion of amino acid 43–56. We also examined expression
levels of b transcript relative to a transcript in keratinocytes
by RT-PCR using a primer set designed to amplify a 267 bp
fragment for a transcript and a 235 bp for b transcript (Fig
7B). In addition to a 267 bp fragment, a band corresponding
to a 235 bp was noted. This band was very faint in PCR
products of RNA from keratinocytes freshly isolated from
skin, and was unchanged in primary-cultured keratinocytes
induced to differentiate after treatment with high-Ca2þ
media. These results show that the spliced variant of Kdap
mRNA is not the major transcript in keratinocytes.
To determine whether this spliced variant was generated
by alternative splicing mechanisms, we searched for the
Kdap gene in the human genome database (provided by
NCBI). An entire sequence of Kdap cDNA segmented into
six exons was found in the locus between 13.1 and 13.2 on
chromosome 19 (Fig 7A): exon 1 encoded for the SS and a
part of N-terminal mature Kdap; and other five exons
encoded for the rest of the amino acid residues. The 50- and
30-flanking sequences of each exon contained conserved
splice acceptor/donor sequences. A nucleotide sequence
missing from the b transcript was identical to exon 3,
indicating that the b transcript was generated by alternative
splicing (exon skipping).
Discussion
Kdap was first identified by Oomizu et al (2000) by
suppression subtractive cDNA cloning of skin from rats at
different embryonal stages of hair differentiation (prehair-
germ vs hair-germ stages). They also identified mouse and
human homologs and their spliced variants. Expression
studies in rat showed that: (1) Kdap mRNA was induced
after the hair-germ stage (quantitative RT-PCR); (2) its
expression was restricted to epithelial tissues in rat embryo
tissues (RT-PCR); and (3) skin expression was confined
to the suprabasal layers of embryonal epidermis (in situ
hybridization).
At the time we initiated our studies, Kdap was not
registered in the GenBank database nor were Oomizu’s
results published. Employing a different strategy, we coupled
an SS trap with differential colony hybridization and isolated
the same gene from a cDNA library constructed with mRNA
from primary-cultured human keratinocytes. Using a wide
spectrum of human and mouse tissues and northern
blotting, we affirmed the epithelium-specific expression of
Kdap and its suprabasal layer-specific expression within
the epidermis. We did note the new finding of low-level
expression by human thymus (Figs 2 and 4C).
Expanding on the findings of Oomizu et al we found that:
(1) human Kdap is secreted by keratinocytes (N-terminal
amino acid sequence functioned as an SS; Kdap protein
was detected in the extracellular fraction of transfected and
non-transfected keratinocytes (Fig 3); and it resided in
lamellar granules of granular keratinocytes and the inter-
cellular space of the stratum corneum (Fig 5); (2) Kdap
protein is confined to the granular layer of normal epidermis
(which is not identical to its mRNA expression pattern);
(3) expression in psoriatic skin is more diffuse, involving
suprabasal layers; (4) mRNA expression is regulated by
keratinocyte differentiation; and (5) spliced variant is
produced by alternative splicing mechanisms and ex-
pressed in keratinocytes only at very low levels (in contrast
to the full-length form).
We observed variation in the molecular weight of Kdap
protein. The molecular weight of Kdap produced by trans-
fected cells was larger than that predicted from the primary
amino acid sequence (Fig 3B). This is due most likely to post-
translational modification in which fatty acids, glycosylphos-
phatidylinositol (GPI) (Chatterjee and Mayor, 2001), or other
small sized molecules are incorporated. Glycosylation may
not take place because Kdap contains neither possible
N-glycosylation sites nor putative O-glycosylation sites (e.g.,
proline-, serine-, threonine-rich regions) (Wilson et al, 1991).
We also observed another type of modification. The
molecular weight of Kdap in crude extracts from psoriatic
and normal skin was two to three times larger than that
detected in transfected and non-transfected keratinocytes
(Fig 3C). This finding suggests that Kdap is polymerized or
cross-linked to polymerized proteins in the skin. Because
polymerization was not found in the extracellular Kdap
proteins, we speculate that Kdap is anchored to structural
proteins by TGase inside keratinocytes, as has been shown
for elafin and cystatins (Zeeuwen et al, 2001; Nakane et al,
2002). But we could not document TGase-dependent cross-
linking of Kdap (data not shown), which may mean that Kdap
polymerization is achieved by other mechanisms.
Since highly polymerized Kdap cannot be solubilized
using our buffer containing Triton X-100 detergent, we may
have lost the majority of Kdap protein during protein
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Figure 7
Human b transcript is generated by alternative splicing mechan-
isms. (A) The organization of human keratinocyte differentiation-
associated protein (Kdap) gene on chromosome 19q13.1 to 13.2 is
represented schematically. The nucleotide sequence of a transcript (a
full-length form) segmented into six exons, and aligned to that of b
transcript with deletion of exon 3. (B) Total RNA was isolated from
keratinocytes that were freshly isolated from neonatal foreskin tissue,
primary cultured, or treated with high Ca2þ medium (day 4). RNA was
examined for mRNA expression of a and b transcripts by RT-PCR using
a primer set (Materials and Methods). Full-length Kdap cDNA was also
PCR amplified as control. PCR products were then size-fractionated
through 8% native PAGE and stained with ethidium bromide.
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extraction. This possibility may thus account for poor
expression of Kdap (in western blotting) in intracellular
fractions of non-transfected primary-cultured keratinocytes
(Fig 3C) and also explain the poor efficiency of secretion by
keratinocytes.
Recent molecular studies on CCE components have
documented the presence of low-molecular-weight
secreted proteins in the protein envelope consisting of an
insoluble complex of proteins, which include SKALP/elafin
(Schalkwijk et al, 1990; Wiedow et al, 1990), secretory
leukocyte proteinase inhibitor (SLPI) (Jin et al, 1997),
lympho-epithelial Kazal-type-related inhibitor (LEKTI) (Ma¨-
gert et al, 2001) cystatin A and M/E (Takahashi et al, 1992;
Sotiropoulou et al, 1997a, b; Zeeuwen et al, 2001),
plasminogen activator inhibitor-type 2 (PAI-2) (Lavker et al,
1998), and bikunin (Cui et al, 1999). All these proteins
possess activity to inhibit either serine or cysteine protei-
nases, some of which are further characterized by restricted
expression to keratinocytes. These inhibitors have been
proposed to play a pivotal role in regulating renewal of
the epidermis and protecting the epidermis from tissue
damages by suppressing activities of endogenous and
exogenous proteinases.
Kdap shares some attributes with these epidermal
proteinase inhibitors, including being a low-molecular-
weight secreted protein and showing a restricted expres-
sion to granular keratinocytes (or CCE). By contrast, Kdap
appears unique with respect to its localization within
lamellar granules and the existence of naturally occurring
spliced variants producing truncated isoforms. In addition,
Kdap might be efficiently secreted by granular keratino-
cytes (Fig 5), suggesting that it may function as a soluble
regulator in the extracellular space.
Because of the similarities to epidermal proteinase
inhibitors, we hypothesized that Kdap possesses activity to
inhibit proteinase and/or growth of microbes. Purified His-
Kdap and His-DHFR were used to determine whether Kdap
could inhibit the activity of cysteine proteinases (papain, ficin,
and cathepsin B) and serine proteinases (chymotrypsin and
trypsin). His-Kdap (10 mM) inhibited the proteinase activity of
papain (100 nM) almost completely, whereas His-DHFR at
the same concentration failed to do so (data not shown).
Although we found anti-proteinase activity of Kdap, the
activity appears 10–100-fold lower than those for other
epidermal inhibitors (e.g., cystatin M/E; Sotiropoulou et al,
1997). Secondly, His-Kdap was assayed for activity to
suppress the growth of microbes (Streptococcus group A,
E. coli, Staphylococcus aureus, and Candida albicans). No
suppressive activity was found with any of the microbes
tested. Kdap is thus likely to possess disparate function from
other low-molecular-weight secreted proteins in the CCE,
although there remains the possibility that post-translational
modification is required to activate Kdap function (His-Kdap
produced in E. coli assumed to have no modification similar
to that in keratinocytes).
Materials and Methods
Cell culture Primary keratinocytes and dermal fibroblasts were
isolated, respectively, from epidermis and dermis of newborn
human foreskins as described before (Girolomoni et al, 2000).
Isolated keratinocytes were maintained and expanded in kerati-
nocyte-SFM media (Invitrogen, Carlsbad, California). Third- to
sixth-passaged keratinocytes (60%–80% confluency) served as a
source of RNA for cDNA library construction and for experiments
examining gene expression. Dermal fibroblasts and COS-1 cells
were cultured in Dulbecco’s modified Eagle’s medium (DMEM)
supplemented with 10% fetal calf serum (FCS).
Cloning of keratinocyte-speciﬁc and SS-encoding genes For
the SS trap, we constructed a cDNA library based on a report by
Tashiro et al (1997). We fused 50-end cDNA sequences from
keratinocyte mRNA in frame to the gene for a variant human
interleukin-2 receptor a (hIL-2Ra) lacking SS in order to produce
hIL-2Ra fusion proteins. Eight thousand independent colonies
were sorted randomly from the library into 163 pools (49 clones per
pool) for SS trap screening (Tashiro et al, 1997; Bonkobara et al,
2003). Plasmid DNA (0.2 mg) from each pool (all colonies in a group)
was transfected into COS-1 cells (1  104) seeded on eight-well
chamber slides (NUNC, Naperville, Illinois) using FuGENE 6 (Roche
Molecular Biochemicals, Indianapolis, Indiana). After 3 d of culture,
the transfectants were assayed by immunocytochemistry for
surface expression of hIL-2Ra; fixed cells were incubated with
0.5 mg per mL of mouse monoclonal antibody (mAb) against hIL-
2Ra (R&D Systems Inc., Minneapolis, Minnesota). After incubation
with biotinylated anti-mouse IgG, avidin-peroxidase and 3-amino-
9-ethylcarbazole (AEC) (DAKO, Carpinteria, California) were
applied and the color stain was examined under light microscopy.
Pools showing surface expression of IL-2Ra were sub-divided
(7 clones per subpool), and then screened further in the above
manner. Finally, cDNA clones in positive subpools were examined
clonally for IL-2Ra surface expression.
cDNA clones with IL-2Ra surface expression were screened by
differential hybridization as described previously (Ariizumi et al,
1997, 2000) for cDNA expressed selectively by keratinocytes.
Selected colonies (193 clones) were transferred to nylon mem-
branes and hybridized with total cDNA probes prepared from
poly(A)þ RNA of keratinocytes or with total cDNA probes of dermal
fibroblasts. This differential hybridization led to selection of 36
cDNA clones with strong hybridization signals for keratinocyte
total cDNA probes, but little or no signals for dermal fibroblast
probes.
The SS-trapped cDNA clones expressed selectively by kerati-
nocytes were examined for nucleotide sequence identities in
GenBank and EST databases using a Blast search program from
the National Center for Biotechnology Information (NCBI). cDNA
clones found in the EST database were evaluated for full-length
nucleotide sequences (SS-trapped cDNA clones contain
50-end sequences only) using 30 rapid amplification of cDNA ends
(30 RACE) system (Invitrogen). The clones with longest cDNA
inserts were selected and their nucleotide sequences were
determined.
Northern blotting and RT-PCR analysis Northern blotting was
performed as described previously (Ariizumi et al, 1995). Poly(A)þ
RNA (2 mg) isolated from primary-cultured human keratinocytes,
dermal fibroblasts, foreskins, and mouse organs were size-
fractionated on a vertical agarose gel, transferred electrophoreti-
cally onto a nylon membrane, and hybridized in buffer containing
1  106 c.p.m. per mL of 32P-labeled cDNA for Kdap or b-actin
gene. After incubating for 16 h at 421C, membranes were washed
and autoradiographed. For tissue distribution of human Kdap
mRNA, a nylon membrane (Human Multiple Tissue Blots pur-
chased from BD Biosciences, Palo Alto, California) with an array of
mRNA (2 mg) isolated from various human organs was hybridized
according to the manufacturer’s recommendations.
To determine Kdap gene expression in total RNA isolated from
mouse epithelial tissues, RT-PCR was performed (Ariizumi et al,
1995). RNA (100 ng) was reverse-transcribed and then PCR-
amplified in one tube (50 mL) containing 0.2 mM dNTP, 1.2 mM
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MgCl2, 20 pmol primers, and SuperScript II RT/Taq mix (Super-
script One-Step RT-PCR System, Invitrogen) using a protocol for
cDNA synthesis (451C for 30 min, and then at 941C for 2 min). The
PCR cycling protocol included incubation at: 941C for denaturation
(45 s); 601C for mouse Kdap or 551C for b-actin primers for
annealing (45 s); 721C for extension (60 s); and 30 cycles. PCR
products (20 mL) were size-fractionated electrophoretically on
1.2% agarose gel and visualized by ethidium bromide staining. The
following primers were used to PCR-amplify cDNA: for mouse
Kdap, 50-CAGCCCAAACCGGACACCAT-30 and 50-GGGGAACT-
GAGGCAAGGAAGATTT-30; and for mouse b-actin, 50-GAGCGG-
GAAATCGTGC GTGACATT-30 and 50-GAAGGTAGTTTCGTGGAT-
GCC-30.
For experiments examining the expression of alternatively
spliced Kdap mRNA in keratinocytes, we used the same conditions
as before, except for a different annealing temperature (581C) and
a primer set: 50-CTGCCGTGGTGCTCCTCTCC-30 and 50-AGTTG-
CGCTCCTCAGTCCTTTCA-30.
Construction of plasmid and adenoviral expression vectors A
plasmid expression vector, pKdap-Fc, encoding a fusion protein of
human Kdap precursor and an Fc portion of human IgG1,
was constructed. Briefly, the entire coding sequence for
Kdap precursor was PCR amplified with 50- and 30-primers
containing EcoRI and XbaI restriction enzyme sites, respectively.
The resulting PCR fragment was inserted in frame into the 50-end of
a coding sequence for the Fc portion that had been subcloned
previously into a CMV-driven expression vector (pcDNA3.1,
Invitrogen).
Adenoviral vectors (Adv) were generated according to the
manufacturer’s manuals of AdEasy system (Quantum Biotechnol-
ogies, Carlsbad, California) with minor modifications (He et al,
1998). A full-length cDNA for the human Kdap precursor was
introduced into a CMV-driven shuttle vector (pShuttle-CMV) using
XhoI and EcoRV restriction sites. After linearization of the shuttle
vector DNA with PmeI, DNA (0.5 mg) was co-transformed into
BJ5183 Escherichia coli (Quantum Biotechnologies) with 0.1 mg of
pAdEasy-1, which encodes a whole genome of Adv type 5 lacking
the E1 and E3 regions. The obtained plasmid clones were
screened for recombinant Adv DNA by total size (433 kb) and
by presence of the Kdap gene. A plasmid sequence in a selected
recombinant DNA (5 mg) was removed by digestion with PacI and
then transfected into a permissive cell line, 293A, using 6 mg of
FuGENE 6. After culturing for 6 d, recombinant viral particles were
recovered by freeze–thawing transfected cells, amplified further by
infection of large numbers of 293A cells, and then purified by
double ultracentrifugation through cesium chloride gradients.
Plaque-forming units (PFU) of purified Adv were determined using
the tissue culture infectious dose (TCID50) method described
previously (He et al, 1998).
Gene delivery In plasmid transfection, COS-1 cells were seeded
at 1 d prior to transfection onto a 60 mm culture dish at a density of
5  105 cells. Cells were incubated overnight in the presence of the
expression vector DNA (2 mg) and 6 mL of FuGENE 6. For Adv-
mediated gene delivery to COS-1 cells and keratinocytes, cells
were seeded on 24-well plates at a density of 1  105 cells per
well. The next day, recombinant Adv was added at multiplication of
infection (MOI) of 250 for COS-1 cells and 500 for keratinocytes.
After incubating at 371C for 90 min, uninfected Adv was washed
out and then cultured for 2 d.
Extraction of proteins and SDS-PAGE/western blotting Two
days after transfection or infection, the culture medium was
replaced with fresh medium. The next day, the supernatant was
recovered and whole-cell extracts were prepared by incubating
cells with 0.3% Triton X-100/phosphate-buffered saline (PBS)
containing 1 mM phenylmethylsulfonyl fluoride (PMSF) and 2 mg
per mL of leupeptin, followed by centrifugation (Shikano et al,
2001). Whole-cell extracts were also prepared from the scales of
psoriatic skin and of dry skin in a healthy individual as described
previously (Zeeuwen et al, 1997). In experiments assaying Kdap
protein expression from the supernatant of cultured keratinocytes
(not transfected), the supernatant was concentrated in volume 10–
20-fold by lyophilization and subsequently rehydrated with a small
volume of buffer.
Aliquots of each fraction prepared from transfected cells or
protein extracts from psoriatic scales were size fractionated on
16.5% Tris-Tricine gels under reduced conditions. Following
electro-transfer onto Hybond-P membrane (Amersham Pharmacia
Biotech, Piscataway, New Jersey), the membranes were blocked
with 5% non-fat dried milk/0.1% Tween 20/PBS and incubated
with 0.1 mg per mL of purified rabbit IgG raised against His-tagged
Kdap recombinant proteins or control IgG. Signals were developed
with horseradish peroxidase (HRP)-conjugated goat anti-rabbit IgG
and ECL plus system (Amersham Pharmacia Biotech).
Production of antibodies against His-tagged recombinant
Kdap protein A bacterial expression vector, pET-hKdap, was
constructed by insertion of a PCR-amplified coding sequence for
human mature Kdap in frame into that for N-terminal 10 
Histidine in an expression vector, pET-16b (Novagen, Madison,
Wisconsin). BL21(DE3) E. coli (Novagen) transformed with pET-
hKdap was treated with 1 mM IPTG for 6 h. After harvesting cells,
whole proteins were extracted by 8 M urea/100 mM sodium
acetate/Tris-HCl, pH 8.0, and applied to affinity purification
with nickel resins (Quiagen). His-tagged Kdap was eluted
from the resins with 8 M urea/100 mM sodium acetate/0.5 M
imidazole, pH 4.5, fractions were collected containing proteins,
and finally refolded by dialysis against 100 mM phosphate buffer
(pH 7.7).
Refolded His-Kdap was used for immunization of rabbits. A
mixture of Kdap recombinant proteins (200 mg per rabbit) and
complete Freund’s adjuvant was injected into rabbits, followed by
three boosts with incomplete Freund’s adjuvant at 3-wk intervals.
Five days after the last boost, serum was collected from
immunized rabbits and affinity purified with beads conjugated with
His-Kdap.
N-terminal sequencing To determine the exact site of signal
peptide cleavage in the Kdap precursor, purified recombinant
Kdap-Fc was subjected to N-terminal sequencing. Briefly, 3 d after
transfection of pKdap-Fc into COS-1 cells, Fc-fusion proteins in
the culture supernatant were allowed to bind to Protein A–agarose
(Sigma, St Louis, Missouri), and then eluted sequentially with 150
mM NaCl/50 mM acetate buffer (pH 4.3) and 150 mM NaCl/50 mM
glycine buffer (pH 2.3). Fractions with highest protein concentra-
tions were selected and applied to SDS-PAGE, followed by
western blotting. A band with reactivity to goat anti-human IgG
Ab was purified by gel extraction and subjected to 15 cycles of N-
terminal sequencing by automated Edman degradation in the
HHMI Protein Chemistry Core Research Facility (UT Southwes-
tern).
Skin samples Biopsies were taken from lesional skin sites of three
individuals with psoriasis. Our study was performed after the ethics
committee approval and informed consent was obtained under the
Declaration of Helsinki Principles. The controls included two
normal individuals (one female and one male) without skin disease
for fluorescence and for in situ hybridization and two different
individuals for immunoelectron microscopy (two males).
Indirect immunoﬂuorescence Human skin cryostat sections
were fixed in cold acetone (201C) for 10 min and incubated with
5% normal goat serum (NGS) in 0.1 M Dulbecco’s PBS for 5 min at
371C. Sections were incubated with anti-Kdap Ab or rabbit control
IgG (diluted at 1:50), secondary antibody goat anti-rabbit IgG
fluorescein isothiocyanate (FITC, Dako, Kyoto, Japan), diluted in
3% bovine serum albumin (BSA) in 0.1 M PBS for 30 min at 371C.
The sections were then mounted in Permafluor (Thermo Shandon,
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Pittsburgh, Pennsylvania) and examined with a Nikon Optiphot 2
microscope equipped for epifluorescence or a confocal laser
inverted microscope (Olympus Fluoview FV300 Optical Elements
Corporation, Dulles, VA). Images were scanned sequentially using
a 40 times objective, and multiple images were Kalman averaged
(n45).
Post-embedding immunogold electron microscopy Skin sam-
ples were obtained from the outer aspect of the arm and thigh, and
were processed for post-embedding immunoelectron microscopy
as previously described (Shimizu et al, 1989). Briefly, samples were
cryoprotected in 20% glycerol/PBS for 1 h at 41C, and plunged in
liquid propane at 1901C using a KF-80 apparatus (Reichert Jung,
Vienna, Austria). After freeze substitution over 3 d at 801C in
methanol and over 2 d at 601C using the AFS apparatus (Leica,
Milton Keynes, UK), the samples were embedded in Lowicryl
K11M resin polymerized by UV light. Ultrathin sections were cut
and collected on pioloform-coated nickel grids. The sections were
pre-incubated in PBS containing 5% NGS, 1% BSA, and 0.1%
gelatin and then incubated with anti-Kdap Ab (1:100 dilution) at
371C for 2 h. After washing with PBS, the sections were incubated
with secondary linker Ab for 2 h at 371C, followed by incubation
with a gold-conjugated antibody for 2 h at 371C. After staining with
alcoholic uranyl acetate (15 min) and Reynolds lead citrate (5 s), the
sections were observed in a Hitachi H7100-transmission electron
microscope (Hitachi, Tokyo, Japan).
In situ hybridization of human skin This assay was performed
using manufacturer’s recommendations of mRNA locator (Ambion,
Austin, Texas). Briefly, frozen skin sections were treated with
proteinase K at room temperature for 20 min. After fixation,
genomic nucleotides were digested with 500 U per mL DNase I at
371C for 1 h. Control sections were treated with RNase (instead of
DNase). For probe preparation, a full-length cDNA of Kdap (441 bp)
was subcloned into a pGEM-7zf() (Promega, Madison, Wiscon-
sin) and used as a template for in vitro RNA synthesis using
MAXIscript (Ambion). Anti-sense and sense (negative control) RNA
probes were synthesized by T7 and SP6, respectively, RNA
polymerase in the presence of biotin-labeled UTP (Invitrogen).
DNase-treated sections were then hybridized at 421C for 24 h with
10 ng per mL biotin-labeled RNA probe. After washing, unhybri-
dized Ribo probes were digested with 1 mg per mL RNase A for 30
min at 371C, and hybridized probes were then visualized by
histochemistry using HRP-labeled streptavidin, avidin-peroxidase,
and AEC reagent.
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